Published in Br Heart J on February 01, 1987
Systemic Lupus Erythematous and Heart Conduction Disorders | NCT02162992
Adult onset polymyositis/dermatomyositis: clinical and laboratory features and treatment response in 75 patients. Ann Rheum Dis (1993) 1.14
Possible association between anti-Ro antibodies and myocarditis or cardiac conduction defects in adults with systemic lupus erythematosus. Ann Rheum Dis (1990) 0.96
Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography. J Neurol (2015) 0.78
Family studies of congenital heart block associated with Ro antibody. Br Heart J (1989) 0.77
Polymyositis and dermatomyositis (first of two parts). N Engl J Med (1975) 18.52
Autoantibodies to nuclear antigens (ANA): their immunobiology and medicine. Adv Immunol (1982) 9.73
Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique. Ann N Y Acad Sci (1975) 5.23
A serum factor in lupus erythematosus with affinity for tissue nuclei. Br Med J (1957) 4.85
The Ro small cytoplasmic ribonucleoproteins: identification of the antigenic protein and its binding site on the Ro RNAs. Proc Natl Acad Sci U S A (1984) 3.51
Connective-tissue disease, antibodies to ribonucleoprotein, and congenital heart block. N Engl J Med (1983) 2.24
Polymyositis: its presentation, morbidity and mortality. Brain (1975) 2.07
Purification and characterization of the Sjögren's syndrome A and B antigens. Clin Exp Immunol (1983) 1.73
Anti-Jo-1 antibody: a marker for myositis with interstitial lung disease. Br Med J (Clin Res Ed) (1984) 1.68
Antibodies to extractable nuclear antigens in 173 patients with DNA-binding positive SLE: an association between antibodies to ribonucleoprotein and Sm antigens observed by counterimmunoelectrophoresis. J Clin Lab Immunol (1982) 1.52
Maternal connective tissue disease and congenital heart block. Demonstration of immunoglobulin in cardiac tissue. N Engl J Med (1985) 1.41
ECG abnormalities in polymyositis. Arch Intern Med (1984) 1.15
Cardiac abnormalities in polymyositis/dermatomyositis. Semin Arthritis Rheum (1982) 1.09
Heart disease in myasthenia gravis. Acta Neurol Scand (1984) 1.01
Congenital complete heart block and connective-tissue disease. N Engl J Med (1983) 1.01
The Jo-1 antibody system in myositis: relationships to clinical features and HLA. J Rheumatol (1982) 0.99
Congenital heart block. Anatomic correlations and review of the literature. Arch Pathol (1974) 0.97
Inflammatory myopathies: Part 2. Ann Neurol (1985) 0.95
Immunological features of polymyositis/dermatomyositis. Springer Semin Immunopathol (1985) 0.92
Antibodies to nuclear antigens in polymyositis: relationship to autoimmune 'overlap syndromes' and carcinoma. Ann Rheum Dis (1981) 0.89
New findings in neonatal lupus syndrome. Am J Dis Child (1984) 0.83
Maternal connective tissue disease and congenital heart block. N Engl J Med (1985) 0.81
Pathogenesis of heart block in a fatal case of dermatomyositis. Br Heart J (1986) 0.79
The postviral fatigue syndrome--an analysis of the findings in 50 cases. J Infect (1985) 4.39
Enteroviral RNA sequences detected by polymerase chain reaction in muscle of patients with postviral fatigue syndrome. BMJ (1991) 3.65
Possible upregulation of hypothalamic 5-hydroxytryptamine receptors in patients with postviral fatigue syndrome. BMJ (1992) 2.64
Myalgic encephalomyelitis--report of an epidemic. J R Coll Gen Pract (1983) 2.64
Postviral fatigue syndrome: persistence of enterovirus RNA in muscle and elevated creatine kinase. J R Soc Med (1988) 2.60
Epidemic myalgic encephalomyelitis. Practitioner (1980) 2.53
Strümpell's familial spastic paraplegia: genetics and neuropathology. J Neurol Neurosurg Psychiatry (1974) 2.32
Immunological abnormalities in patients who had the oculomucocutaneous syndrome associated with practolol therapy. Lancet (1976) 2.31
Postviral fatigue syndrome. Crit Rev Neurobiol (1988) 2.19
The symptoms of chronic fatigue syndrome are related to abnormal ion channel function. Med Hypotheses (2000) 2.10
Fatigue and basal ganglia. J Neurol Sci (2000) 1.82
The effect of anti-alpha4 integrin antibody on brain lesion activity in MS. The UK Antegren Study Group. Neurology (1999) 1.82
Antiviral pathway activation in patients with chronic fatigue syndrome and acute infection. Clin Infect Dis (2001) 1.72
Antibody to Coxsackie B virus in diagnosing postviral fatigue syndrome. BMJ (1991) 1.69
'Onion bulb' formations in the central and peripheral nervous system in association with multiple sclerosis and hypertrophic polyneuropathy. Brain (1977) 1.56
Myasthenic crisis. QJM (2008) 1.52
Serum folate and chronic fatigue syndrome. Neurology (1993) 1.47
Gangliosides and neurological diseases. BMJ (1992) 1.43
Uveitis and retinal vasculitis in acute experimental allergic encephalomyelitis in the Lewis rat: an ultrastructural study. Exp Eye Res (1993) 1.42
Acute cervical hyperextension-hyperflexion injury may precipitate and/or exacerbate symptomatic multiple sclerosis. Eur J Neurol (2001) 1.37
Cell-mediated immunity to myelin basic protein in acute disseminated encephalomyelitis. Neurology (1974) 1.35
Effect of high doses of essential fatty acids on the postviral fatigue syndrome. Acta Neurol Scand (1990) 1.33
Paraneoplastic limbic encephalitis: clinico-pathological correlations. J Neurol Neurosurg Psychiatry (1990) 1.26
Mitochondrial abnormalities in the postviral fatigue syndrome. Acta Neuropathol (1991) 1.22
Landry-Guillain-Barré-Strohl syndrome and immune-complex nephritis. Lancet (1973) 1.22
Neurological dysfunction in two patients receiving captopril and cimetidine. Lancet (1980) 1.20
Immune disease and HLA associations with myasthenia gravis. J Neurol Neurosurg Psychiatry (1980) 1.17
Delayed hypersensitivity to encephalitogenic protein in disseminated encephalomyelitis. Lancet (1968) 1.17
Amplification and identification of enteroviral sequences in the postviral fatigue syndrome. Br Med Bull (1991) 1.17
Neurological aspects of mycoplasmal infection. Acta Neurol Scand (1986) 1.16
Cytomegalovirus in autoimmunity: T cell crossreactivity to viral antigen and autoantigen glutamic acid decarboxylase. Proc Natl Acad Sci U S A (2001) 1.13
Changes in natural killer cell phenotype in patients with post-viral fatigue syndrome. Clin Exp Immunol (1991) 1.11
Palatal myoclonus successfully treated with clonazepam. J Neurol Neurosurg Psychiatry (1990) 1.07
Studies on the nature of autoimmunity in myasthenia gravis. Evidence for an immunodeficiency type. Ann N Y Acad Sci (1976) 1.04
Letter: Immune response genes in myasthenia gravis. Lancet (1973) 1.02
Allergic encephalomyelitis: effect of complement depletion with cobra venom. Proc Soc Exp Biol Med (1971) 1.02
Immunologic mechanisms in experimental encephalomyelitis in nonhuman primates. Arch Neurol (1973) 1.00
In vivo magnetic resonance spectroscopy in chronic fatigue syndrome. Prostaglandins Leukot Essent Fatty Acids (2004) 0.99
Letter: Impaired cell-mediated immunity in human brain tumours. Lancet (1975) 0.98
Search for retrovirus in the chronic fatigue syndrome. J Clin Pathol (1992) 0.97
GAD65-Reactive T cells in a non-diabetic stiff-man syndrome patient. J Autoimmun (1999) 0.96
Letter: Rosette tests following thymectomy. Lancet (1975) 0.96
Plasma-exchange combined with immunosuppressive therapy in myasthenia gravis. Lancet (1979) 0.95
A correlation between severity of migraine and delayed gastric emptying measured by an epigastric impedance method. Br J Clin Pharmacol (1990) 0.95
Nifedipine in the treatment of myotonia in myotonic dystrophy. J Neurol Neurosurg Psychiatry (1987) 0.95
Late onset of Guillain-Barré syndrome. J Neuroimmunol (1982) 0.95
HLA-B8 in polymyositis. N Engl J Med (1978) 0.95
Cell-mediated hypersensitivity to neural antigens. Occurrence in human patients and nonhuman primates with neurological diseases. Arch Neurol (1972) 0.93
The role of viral infection in polymyositis, dermatomyositis and chronic fatigue syndrome. Baillieres Clin Neurol (1993) 0.93
A case of progressive encephalomyelitis with rigidity and positive antiglutamic acid decarboxylase antibodies [corrected]. J Neurol Neurosurg Psychiatry (1991) 0.93
Demonstration of delayed recovery from fatiguing exercise in chronic fatigue syndrome. Eur J Neurol (1999) 0.92
Immunological features of polymyositis/dermatomyositis. Springer Semin Immunopathol (1985) 0.92
Immunological studies in pre-eclamptic toxaemia. Br Med J (1976) 0.92
Molecular mimicry in type 1 diabetes: immune cross-reactivity between islet autoantigen and human cytomegalovirus but not Coxsackie virus. Ann N Y Acad Sci (2002) 0.91
Hyperacute experimental allergic neuritis. Res Commun Chem Pathol Pharmacol (1971) 0.91
The ophthalmoplegic form of the Guillain-Barre-syndrome: an immunologic study. Acta Ophthalmol (Copenh) (1973) 0.91
Immunopathological mechanisms of allergic neuritis in animals, primates, and man. Trans Am Neurol Assoc (1969) 0.91
Recurrent acute necrotizing hemorrhagic incephalopathy. Acta Neuropathol (1972) 0.90
Acute disseminated encephalomyelitis. Br J Clin Pract (1974) 0.89
Diffuse myelitis associated with rubella vaccination. Br Med J (1977) 0.88
Acute necrotizing hemorrhagic encephalopathy. Postgrad Med (1973) 0.88
Behavioural problems associated with the chronic fatigue syndrome. Br J Psychol (1993) 0.88
Hereditary chorea without dementia. J Neurol Neurosurg Psychiatry (1977) 0.88
Brain damage complicating septic shock: acute haemorrhagic leucoencephalitis as a complication of the generalised Shwartzman reaction. J Neurol Neurosurg Psychiatry (1979) 0.87
Disturbance of regulatory lymphocyte subsets in polymyositis. Ann Neurol (1984) 0.87
Metabolism of immunoglobulin A, lymphocyte function, and histocompatibility antigens in patients on anticonvulsants. J Neurol Neurosurg Psychiatry (1978) 0.87
Enterovirus in the chronic fatigue syndrome. Ann Intern Med (1994) 0.86
Neuroanatomical anomalies in autoimmune mice. Acta Neuropathol (1987) 0.86
Studies on enterovirus in patients with chronic fatigue syndrome. Clin Infect Dis (1994) 0.86
Brain abnormalities in immune defective mice. Brain Res (1990) 0.86
Treatment of multiple sclerosis: beyond the NICE guidelines. QJM (2005) 0.85
Letter: Decreased serum-IgA in myasthenia gravis. Lancet (1976) 0.85
Abnormal extracellular material in the levator palpebrae superioris complex in congenital ptosis. Arch Ophthalmol (1995) 0.85
Experimental autoimmune demyelinating diseases: experimental allergic encephalomyelitis and experimental allergic neuritis. Biomedicine (1975) 0.85
Rat or human acetylcholine-receptor antigen for investigation of myasthenia gravis? Lancet (1979) 0.84
Effects of the autoimmune uterine/maternal environment upon cortical ectopias, behavior and autoimmunity. Brain Res (1991) 0.84
A behavior profile of the MRL/Mp lpr/lpr mouse and its association with hydrocephalus. Brain Behav Immun (1992) 0.84
Does Toxoplasma cause polymyositis? Report of a case of polymyositis associated with toxoplasmosis and a critical review of the literature. Acta Neuropathol (1983) 0.83
Replication of the herpes simplex virus type 1 RL1 mutant 1716 in primary neuronal cell cultures--possible relevance to use as a viral vector. J Neurol Sci (2000) 0.83
Bilateral internuclear ophthalmoplegia as a false localizing sign. J R Soc Med (1991) 0.82
The inflammatory process in polymyositis: monoclonal antibody analysis of muscle and peripheral blood immunoregulatory lymphocytes. J Neurol Neurosurg Psychiatry (1987) 0.82
Histocompatibility antigens associated with motor-neurone disease. Lancet (1976) 0.82
Possible evidence for a Shwartzman reaction in pseudomembranous colitis. Digestion (1982) 0.81
Experimental allergic neuritis: a new experimental approach. J Neurol Neurosurg Psychiatry (1973) 0.81
Abnormalities of lymphocyte subsets in polymyositis. Br Med J (Clin Res Ed) (1983) 0.81